Intravenous Procainamide Facilitates Ventricular Arrhythmia Induction in Brugada Syndrome

CHEST Journal ◽  
2004 ◽  
Vol 126 (4) ◽  
pp. 827S
Author(s):  
Craig A. McPherson ◽  
Fadi Alsous ◽  
Eteri Byazrova
2021 ◽  
Vol 41 (5) ◽  
pp. 15-22
Author(s):  
L. Douglas Smith ◽  
Sarah Gast ◽  
Danielle F. Guy

Background Brugada syndrome is a genetic disorder of cardiac conduction that predisposes patients to spontaneous ventricular arrhythmia and sudden cardiac death. Although Brugada syndrome is one of the most common causes of sudden cardiac death, patients presenting with the syndrome often go misdiagnosed. This error has potentially fatal consequences for patients, who are at risk for sudden cardiac death without appropriate management. Objective To increase the critical care professional’s knowledge of Brugada syndrome through detailed description of the characteristic electrocardiographic findings, an algorithmic approach to electrocardiogram evaluation, and a case report of a patient with a previously missed diagnosis of Brugada syndrome. The essential concepts of epidemiology, pathophysiology, clinical presentation, risk stratification, and management are reviewed for critical care professionals who may encounter patients with the syndrome. Diagnosis Patients typically present with syncope or cardiac arrest and an abnormal electrocardiographic finding of ST-segment elevation in the precordial leads. The diagnosis of Brugada syndrome centers on identification of its electrocardiographic characteristics by critical care professionals who routinely evaluate electrocardiograms. Critical care professionals, especially nurses and advanced practice nurses, should be proficient in recognizing the electrocardiographic appearance of Brugada syndrome and initiating appropriate management. Interventions Management strategies include prevention of sudden cardiac death through lifestyle modification and placement of an implantable cardioverter-defibrillator. Critical care professionals should be aware of commonly used medications that may exacerbate ventricular arrhythmia and place patients at risk for sudden cardiac death. Conclusion Increased awareness of Brugada syndrome among critical care professionals can decrease patient morbidity and mortality.


2019 ◽  
Vol 123 (12) ◽  
pp. 1962-1966 ◽  
Author(s):  
Ahmed A.Y. Ragab ◽  
Charlotte A. Houck ◽  
Lisette J.M.E. van der Does ◽  
Eva A.H. Lanters ◽  
Agnes J.Q.M. Muskens ◽  
...  

2003 ◽  
Vol 42 (9) ◽  
pp. 1624-1631 ◽  
Author(s):  
Hiroshi Morita ◽  
Shiho Takenaka Morita ◽  
Satoshi Nagase ◽  
Kimikazu Banba ◽  
Nobuhiro Nishii ◽  
...  

Heart Rhythm ◽  
2005 ◽  
Vol 2 (5) ◽  
pp. S112 ◽  
Author(s):  
Atsuyuki Watanabe ◽  
Hiroshi Morita ◽  
Kengo Fukushima Kusano ◽  
Kimikazu Banba ◽  
Nobuhiro Nishii ◽  
...  

2015 ◽  
Vol 39 (2) ◽  
pp. 198-201 ◽  
Author(s):  
MUKUND A. PRABHU ◽  
REYNOLD AGUSTINUS ◽  
JAYAPRAKASH SHENTHAR

2018 ◽  
Vol 33 (2) ◽  
pp. 2537-2552 ◽  
Author(s):  
Jens-Peter David ◽  
Ulrike Lisewski ◽  
Shawn M. Crump ◽  
Thomas A. Jepps ◽  
Elke Bocksteins ◽  
...  

2002 ◽  
Vol 39 ◽  
pp. 112
Author(s):  
Masaomi Kimura ◽  
Takao Kobayashi ◽  
Shingen Ohwada ◽  
Shingo Sasaki ◽  
Tomonori Igarashi ◽  
...  

EP Europace ◽  
2016 ◽  
Vol 18 (10) ◽  
pp. 1501-1506 ◽  
Author(s):  
Bieke Dobbels ◽  
Dieter De Cleen ◽  
Joris Ector

Author(s):  
Fouad Laboudi ◽  
Ghizlane Slimani ◽  
Mohamed Essaid Gourani ◽  
Abderrazzak Ouanass

Brugada syndrome is a rare genetic disease, of autosomal dominant inheritance with low penetrance, manifested by ST segment elevation at right precordial V1, V2 and V3, and right branch block aspect. to the electrocardiogram. It exposes to a high risk of ventricular arrhythmia that can cause syncope and even sudden death, on a structurally healthy heart.We report here the case of a young patient of 25 years who has a syndrome of Brugada induced by a neuroleptic. To our knowledge, this is the first reported case of Brugada syndrome induced by a neuroleptic Morocco. Therapeutic management is based on Amiodarone and betablockers. Regular monitoring of the ECG should, however, be performed on patients taking psychotropic drugs and also on associations.


Sign in / Sign up

Export Citation Format

Share Document